Fundación Pública Galega de Medicina Xenómica
Centro de investigación
University of Southampton
Southampton, Reino UnidoPublicacións en colaboración con investigadores/as de University of Southampton (16)
2023
-
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
Nature Genetics, Vol. 55, Núm. 12, pp. 2065-2074
2021
-
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0)
Nature Genetics
-
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Nature Genetics, Vol. 53, Núm. 1, pp. 65-75
2019
-
Correction to: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8)
Nature Genetics
-
Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)
Nature Communications
-
Erratum to: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (Nature Communications, (2018), 9, 1, (3707), 10.1038/s41467-018-04989-w)
Nature Communications
2018
-
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
Nature Genetics, Vol. 50, Núm. 7, pp. 968-978
-
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Nature Genetics, Vol. 50, Núm. 7, pp. 928-936
-
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Nature Communications, Vol. 9, Núm. 1
-
Genetic testing and clinical management practices for variants in non-BRCA1/2 breast (and breast/ovarian) cancer susceptibility genes: An international survey by the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) clinical working group
JCO Precision Oncology, Vol. 2
-
Germline variation at 8q24 and prostate cancer risk in men of European ancestry
Nature Communications, Vol. 9, Núm. 1
-
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
Nature Communications, Vol. 9, Núm. 1
2016
2015
-
BRCA1 Circos: A visualisation resource for functional analysis of missense variants
Journal of Medical Genetics, Vol. 52, Núm. 4, pp. 224-230
2008
-
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3
Nature Genetics, Vol. 40, Núm. 5, pp. 623-630
-
Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer
Human Molecular Genetics, Vol. 17, Núm. 23, pp. 3720-3727